Resolvyx Pharmaceuticals
Cambridge, Massachusetts, United States
About Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals is developing an entirely new class of medicines called Resolvins. Resolvins are naturally-occurring, small molecule lipid mediators with the potential to treat a wide range of inflammatory diseases. Unlike most anti-inflammatory drugs which suppress the body's inflammatory response, Resolvins work by activating the body's own mechanisms for shutting off, or resolving, inflammation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $45.7M
- Last round: Series Unknown (Nov 2010)
- Website: resolvyx.com
- Phone: 781-541-5045
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/resolvyx-pharmaceuticals-2470131 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.